Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
15,279 results
- Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug): Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Drug-Drug Interaction Between Colchicine and Ritonavir: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Between Colchicine and Ritonavir: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00983515).
- Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study Between AT1001 (Migalastat Hydrochloride) and Agalsidase in Participants With Fabry Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Drug-Drug Interaction Study Between Colchicine and Atorvastatin: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study Between Colchicine and Atorvastatin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00960323).
- Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01303445).
- Drug-Drug Interaction Study of Colchicine and Theophylline: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Colchicine and Theophylline: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00983905).
- Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Evobrutinib and Transporter Substrates: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05064488).
- Drug-Drug Interaction Study of Qualaquin and Midazolam: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Qualaquin and Midazolam: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00785486).
- Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Drug-Drug Interaction Study to Estimate the Effect of PF-07321332/Ritonavir and Ritonavir on Midazolam in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Drug-drug Interaction Study: Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01380743).
- Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Drug-drug Interaction Trial Between Rifampicin and BI 409306 in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DryShield vs Cotton Roll Isolation During Sealants Placement: Efficiency and Patient Preference: Complete Statistical AnalysisIndependent statistical analysis of DryShield vs Cotton Roll Isolation During Sealants Placement: Efficiency and Patient Preference: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL): Complete Statistical AnalysisIndependent statistical analysis of DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DS-5565 Phase III Study for Post-herpetic Neuralgia: Complete Statistical AnalysisIndependent statistical analysis of DS-5565 Phase III Study for Post-herpetic Neuralgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02318719).
- DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: Complete Statistical AnalysisIndependent statistical analysis of DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]: primary endpoint results, effect estimate…
- DSAEKIndependent statistical analysis of Early Experience With Descemet's Stripping Automated Endothelial Keratoplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744796).
- DSAPIndependent statistical analysis of DSAP Treatment Comparison: 2% Lovastatin/ 2% Cholesterol vs 2% Lovastatin Alone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DSASIndependent statistical analysis of Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- DSC2UIndependent statistical analysis of An Online Health Tool About Down Syndrome: Down Syndrome Clinic to You: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- DSSIndependent statistical analysis of rTMS and Retraining in Focal Hand Dystonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01738581).
- DSTIndependent statistical analysis of CoolSculpting of the Distal Thigh Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02335749).
- DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dual Antiplatelet Therapy Adherence With Reminder App Usage: Complete Statistical AnalysisIndependent statistical analysis of Dual Antiplatelet Therapy Adherence With Reminder App Usage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05071027).
- Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices: Complete Statistical AnalysisIndependent statistical analysis of Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- DUAL™Independent statistical analysis of A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and…
- DUAOIndependent statistical analysis of Doppler-Guided Uterine Artery Occlusion (DUAO) Device for Fibroid Related Bleeding: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00496080).
- DUARTIndependent statistical analysis of Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder: primary endpoint results, effect estimate with confidence interval, sample-size…
- DULCISIndependent statistical analysis of CO2-Laser Treatment in Patients With Diabetic Infected Foot Ulcers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02677779).
- Dulcolax vs Placebo in Functional Constipation: Complete Statistical AnalysisIndependent statistical analysis of Dulcolax vs Placebo in Functional Constipation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00526097).
- Duloxetine for Chronic Depression: a Double-blind Study: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Chronic Depression: a Double-blind Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00360724).
- Duloxetine for Menopausal Depression: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Menopausal Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01117857).
- Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114127).
- Duloxetine for the Treatment of Chronic Pelvic Pain: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine for the Treatment of Chronic Pelvic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01451606).
- Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Duloxetine Treatment in Elderly With Dysthymia: Complete Statistical AnalysisIndependent statistical analysis of Duloxetine Treatment in Elderly With Dysthymia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01852383).
- DUO-EIndependent statistical analysis of Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- DUO-OIndependent statistical analysis of Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients: primary endpoint results, effect estimate with confidence…
- Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: Complete Statistical AnalysisIndependent statistical analysis of Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52): Complete Statistical AnalysisIndependent statistical analysis of Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: Complete Statistical AnalysisIndependent statistical analysis of DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Durability of Hypertonic Saline for Enhancing Mucociliary Clearance in Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Durability of Two Skin Barrier Protectants (SBP): Complete Statistical AnalysisIndependent statistical analysis of Durability of Two Skin Barrier Protectants (SBP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05756348).
- DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery: Complete Statistical AnalysisIndependent statistical analysis of DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00387829).
- Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of Dural Puncture Epidural Versus Epidural Anesthesia for Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03915574).
- Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine: Complete Statistical AnalysisIndependent statistical analysis of Duration of Analgesia After Popliteal Fossa Nerve Blockade: Effects of Dexamethasone and Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…